Effect of beraprost sodium on arterial stiffness in patients with type 2 diabetic nephropathy

BACKGROUND: Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD). Cardiovascular (CV) complications are the most common cause of death among ESRD patients. Beraprost sodium (BPS) is a prostacyclin analog with vasodilatory and antiplatelet effects. METHODS: This is a multicente...

Descripción completa

Detalles Bibliográficos
Autores principales: Na, Ki Young, Kim, Dong Ki, Kim, Sung Gyun, Lee, Young-Ki, Lim, Chun Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765998/
https://www.ncbi.nlm.nih.gov/pubmed/24066672
http://dx.doi.org/10.1186/1745-6215-14-275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765998/
https://www.ncbi.nlm.nih.gov/pubmed/24066672
http://dx.doi.org/10.1186/1745-6215-14-275

Ejemplares similares